Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review

详细信息    查看全文

• 作者：Carolyn L. Lekavich ; Debra J. Barksdale ; Virginia Neelon…
• 关键词：Heart failure preserved ejection fraction (HFpEF) ; Diastolic heart failure ; Treatment ; Diagnostic guidelines
• 刊名：Heart Failure Reviews
• 出版年：2015
• 出版时间：November 2015
• 年：2015
• 卷：20
• 期：6
• 页码：643-653
• 全文大小：470 KB
• 参考文献：1.Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62(16):e147–e239. doi:10.-016/?j.?jacc.-013.-5.-19 PubMed CrossRef
  2.Wong CM, Hawkins NM, Jhund PS, MacDonald MR, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, Petrie MC, McMurray JJ (2013) Clinical characteristics and outcomes of young and very young adults with heart failure: the CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity). J Am Coll Cardiol 62(20):1845-854. doi:10.-016/?j.?jacc.-013.-5.-72 PubMed CrossRef
  3.Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355:251-59PubMed CrossRef
  4.Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB (2015) Heart disease and stroke statistics-015 update: a report from the American Heart Association. Circulation 131(4):e29–e322. doi:10.-161/?cir.-000000000000152-/span> PubMed CrossRef
  5.AlJaroudi W, Alraies MC, Halley C, Rodbriguez I, Grim RA, Thomas JD, Jaber WA (2012) Impact of progression of diastolic dysfunction on mortality in patients with normal ejection fraction. Circulation 1(24):24-0
  6.Gladden JD, Linke WA, Redfield MM (2014) Heart failure with preserved ejection fraction. Pflugers Arch. doi:10.-007/?s00424-014-1480-8 PubMed Central PubMed
  7.Little WC, Zile MR (2012) HFpEF: cardiovascular abnormalities not just comorbidities. Circ Heart Fail 5(6):669-71. doi:10.-161/?circheartfailure--12.-72265 PubMed CrossRef
  8.Borlaug BA, Kass DA (2011) Ventricular-vascular interaction in heart failure. Cardiol Clin 29(3):447-59. doi:10.-016/?j.?ccl.-011.-6.-04 PubMed CrossRef
  9.Borlaug BA, Jaber WA, Ommen SR, Lam CS, Redfield MM, Nishimura RA (2011) Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction. Heart 97(12):964-69. doi:10.-136/?hrt.-010.-12787 PubMed Central PubMed CrossRef
  10.Borlaug BA, Olson TP, Lam CS, Flood KS, Lerman A, Johnson BD, Redfield MM (2010) Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol 56(11):845-54. doi:10.-016/?j.?jacc.-010.-3.-77 PubMed Central PubMed CrossRef
  11.Paulus WJ, Tschope C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62(4):263-71. doi:10.-016/?j.?jacc.-013.-2.-92 PubMed CrossRef
  12.Pickering TG (2004) Reflections in hypertension: heart failure and hypertension: the diastolic dilemma. J Clin Hypertens (Greenwich) 6(11):647-50CrossRef
  13.Borlaug BA, Paulus WJ (2011) Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J 32(6):670-79. doi:10.-093/?eurheartj/?ehq426 PubMed Central PubMed CrossRef
  14.Antonini-Canterin F, Poli S, Vriz O, Pavan D, Bello V, Nicolosi G (2013) The ventricular-arterial coupling: from basic pathophysiology to clinical application in the echocardiography laboratory. J Cardiovas Echocardiogr 23(4):91-5. doi:10.-103/-211-4122.-27408 CrossRef
  15.Lam CS, Shah AM, Borlaug BA, Cheng S, Verma A, Izzo J, Oparil S, Aurigemma GP, Thomas JD, Pitt B, Zile MR, Solomon SD (2013) Effect of antihypertensive therapy on ventricular-arterial mechanics, coupling, and efficiency. Eur Heart J 34(9):676-83. doi:10.-093/?eurheartj/?ehs299 PubMed CrossRef
  16.Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22(2):107-33. doi:10.-016/?j.?echo.-008.-1.-23 PubMed CrossRef
  17.Brutsaert DL, Sys SU, Gillebert TC (1993) Diastolic failure: pathophysiology and therapeutic implications. J Am Coll Cardiol 22(1):318-25PubMed CrossRef
  18.Libby PBE (2008) Braunwald’s heart disease: a textbook of cardiovascular medicine. Philadelphia: Saunders/Elsevier. Available via OC
• 作者单位：Carolyn L. Lekavich (1) (2)
  Debra J. Barksdale (2)
  Virginia Neelon (3)
  Jia-Rong Wu (2)
  
  1. Division of Cardiovascular Medicine, Duke University Medical Center, Duke North, Erwin Road, Suite 7400, DUMC Box 3126, Durham, NC, 27710, USA
  2. School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
  3. Biobehavioral Laboratory, School of Nursing, University of North Carolina, Chapel Hill, NC, USA
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Cardiology
  
• 出版者：Springer Netherlands
• ISSN：1573-7322

文摘

In the USA, 5.7 million Americans ?0 years have heart failure (HF) and heart failure preserved ejection fraction (HFpEF) accounts for at least 50 % of all hospital admissions for HF. HFpEF has no single guideline for diagnosis or treatment, the patient population is heterogeneously and inconsistently described, and longitudinal studies are lacking. The primary aims of this manuscript were to present an integrated review of the current state of the science on HFpEF, demonstrate gaps in the literature and provide the rationale for the design and implementation of future research to yield insights into the syndrome of HFpEF. The scientific literature was comprehensively reviewed on HFpEF pathophysiology, patient characteristics, diagnostic criteria, echocardiography biomarkers, treatment approaches and outcomes. Discrepancies in patient characteristics, diagnostic criteria, study methods and echocardiographic biomarkers were identified. This review indicates that no single test or guideline exists for diagnosis or treatment for HFpEF; heterogeneity of the population is complicated by multiple comorbidities that factor into etiology, race and age are likely important factors that define the phenotype, and limited information is available that designates early markers of impending HFpEF. Studies designed and adequately powered to study the impact of race and age along with consistent use of HFpEF diagnostic criteria are critically needed to further incident HFpEF research. Keywords Heart failure preserved ejection fraction (HFpEF) Diastolic heart failure Treatment Diagnostic guidelines